Senseonics Holdings, Inc. (NASDAQ:SENS – Get Free Report) Director Douglas Roeder acquired 17,041 shares of the business’s stock in a transaction that occurred on Friday, November 13th. The shares were acquired at an average cost of $10.32 per share, for a total transaction of $175,863.12. Following the completion of the acquisition, the director owned 189,712 shares of the company’s stock, valued at $1,957,827.84. This trade represents a 9.87% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Senseonics Stock Up 3.0%
NASDAQ:SENS traded up $0.32 during trading hours on Monday, reaching $10.90. The company’s stock had a trading volume of 2,629,528 shares, compared to its average volume of 703,179. The stock has a 50 day moving average price of $9.17 and a two-hundred day moving average price of $7.33. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.60 and a current ratio of 5.92. The company has a market capitalization of $455.65 million, a P/E ratio of -4.74 and a beta of 1.04. Senseonics Holdings, Inc. has a 12 month low of $4.79 and a 12 month high of $13.98.
Senseonics (NASDAQ:SENS – Get Free Report) last announced its earnings results on Monday, November 9th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics had a negative net margin of 204.01% and a negative return on equity of 186.11%. The company had revenue of $19.56 million for the quarter. Equities analysts predict that Senseonics Holdings, Inc. will post -2.20 EPS for the current fiscal year.
Hedge Funds Weigh In On Senseonics
A number of large investors have recently made changes to their positions in the business. Empowered Funds LLC purchased a new stake in shares of Senseonics during the 3rd quarter valued at $621,000. Ieq Capital LLC purchased a new position in Senseonics during the 3rd quarter worth $215,000. StoneX Group Inc. purchased a new position in Senseonics during the 3rd quarter worth $128,000. Traynor Capital Management Inc. purchased a new position in Senseonics during the 3rd quarter worth $152,000. Finally, State of Wyoming increased its position in Senseonics by 27.2% during the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock valued at $152,000 after buying an additional 3,199 shares in the last quarter. 12.36% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on SENS shares. Weiss Ratings raised Senseonics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. Barclays boosted their target price on shares of Senseonics from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 10th. Wall Street Zen upgraded shares of Senseonics from a “sell” rating to a “hold” rating in a report on Saturday. Stifel Nicolaus reissued a “hold” rating and set a $10.00 price target (up from $9.00) on shares of Senseonics in a research report on Tuesday, November 10th. Finally, Mizuho raised their price target on shares of Senseonics from $18.00 to $20.00 and gave the company an “outperform” rating in a report on Tuesday, November 10th. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $14.40.
Check Out Our Latest Analysis on SENS
About Senseonics
Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.
Featured Articles
- Five stocks we like better than Senseonics
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.
